Vetter Pharma-Fertigung, a provider of aseptically pre-filled injection systems, has formed a new subsidiary, Vetter Pharma International.
With a scheduled launch date of April 1, 2009, Vetter Pharma International (VPI) will be responsible for all Vetter sales, marketing and customer service activities on a worldwide level.
Peter Soelkner has been named managing director, and Oskar Gold will serve as vice president of the new entity. Headquarters will be in Ravensburg, Germany, and Vetter Pharma International USA will be located in Yardley, Pennsylvania.
Mr Soelkner said: The formation of VPI allows us to better position ourselves as a worldwide leader in pre-filled aseptic injection solutions. By creating an entity that focuses exclusively on sales, marketing and customer service on a global level, Vetter will move significantly closer to the international market and can build even stronger relationships with our clients and prospects throughout the world.
Vetter is specialist in aseptic filling of syringes, cartridges and vials. Vetter also produces its own injection systems, as the Vetter Lyo-Ject dual-chamber syringe. Vetter has experience in handling client products and processes approved by the FDA, the EMEA and other authorities.
Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product.